Ratios in Focus: Analyzing Tonix Pharmaceuticals Holding Corp (TNXP)’s Price-to-Cash and Price-to-Free Cash Flow

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) closed at $0.60 down -15.47% from its previous closing price of $0.71. In other words, the price has decreased by -$15.47 from its previous closing price. On the day, 4.28 million shares were traded. TNXP stock price reached its highest trading level at $0.6288 during the session, while it also had its lowest trading level at $0.58.

Ratios:

For a deeper understanding of Tonix Pharmaceuticals Holding Corp’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.87 and its Current Ratio is at 1.47. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.06.

On April 18, 2019, ROTH Capital Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $4.

ROTH Capital Upgraded its Neutral to Buy on August 18, 2017, while the target price for the stock was maintained at $6.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNXP now has a Market Capitalization of 7004730 and an Enterprise Value of 4567015. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.58 while its Price-to-Book (P/B) ratio in mrq is 0.41. Its current Enterprise Value per Revenue stands at 0.446 whereas that against EBITDA is -0.045.

Stock Price History:

The Beta on a monthly basis for TNXP is 2.14, which has changed by -0.9896978 over the last 52 weeks, in comparison to a change of 0.24704397 over the same period for the S&P500. Over the past 52 weeks, TNXP has reached a high of $60.16, while it has fallen to a 52-week low of $0.60. The 50-Day Moving Average of the stock is -84.30%, while the 200-Day Moving Average is calculated to be -94.41%.

Shares Statistics:

For the past three months, TNXP has traded an average of 1.04M shares per day and 4162250 over the past ten days. A total of 58.61M shares are outstanding, with a floating share count of 9.83M. Insiders hold about 0.01% of the company’s shares, while institutions hold 7.57% stake in the company. Shares short for TNXP as of 1718323200 were 1764755 with a Short Ratio of 1.70, compared to 1715731200 on 24549. Therefore, it implies a Short% of Shares Outstanding of 1764755 and a Short% of Float of 42.169996999999995.

Most Popular